Monday , October 23 2017
Home / Letter From The Editor (page 88)

Letter From The Editor

Letter from the Editor #511

Obesity and weight control in our patients continues to be big news each and every week. The new issue of the ADA magazine, “Diabetes Forecast,” has an 8 page spread on surgery for weight loss. The article does a great job of showing the benefits versus the risks of bariatric surgery. ...

Read More »

Letter from the Editor #510

It appears that the FDA and Congress are trying to deal a final blow to GSK’s Avandia. The legislators have spent hundreds of hours reviewing tons of research and have decided that GSK withheld info about the potential for problems. (See Item #1.) To their credit GSK has decided to ...

Read More »

Letter from the Editor #509

Last week we had a commentary from one of our feature writers, Sheri Colberg, Ph.D., FACSM, on the program with Dr. Mehmet Oz and Oprah Winfrey about diabetes. At first I thought that it would blow over and patients would forget what they had heard, but this week in a ...

Read More »

Letter from the Editor #508

Last week two of the most influential people on healthcare caused an uproar among diabetes experts. Dr. Mehmet Oz and Oprah Winfrey did a show about the diabetes problem titled "America’s Silent Killer." While most of us think that any information on how big the problem of diabetes is good, ...

Read More »

Letter from the Editor #507

Last week there was a lot of press about the approval of Victoza (c) liraglutide, the once-a-day GLP-1 mimetic, made by Novo Nordisk. This drug, which works like exenatide, gives practitioners another choice of therapy for patients. If you read all the articles on the internet you will find a ...

Read More »

Letter from the Editor #506

Recently there has been a great deal of attention placed on pharmacogenomics and how drugs will work with patients who have variants of different genes. Now this same gene variant testing may identify which patients are more likely to get diabetes. Recently an international team of researchers analyzed about 2.5 ...

Read More »

Letter from the Editor #505

Looks like there is a real battle ahead for reform to health care. The change of Senators in the state of Massachusetts has altered the power in the Senate and changes the whole future of healthcare reform. So get ready for a lot of press coverage and no action. *** ...

Read More »

Letter from the Editor #504

This is the time of year when JP Morgan has their investor meetings and all the companies in the diabetes business get to report. Our good friend at Diabetic Investor, Dave Kliff, was on hand and shared some of his insights on the meeting. According to Dave, the big winners ...

Read More »

Letter from the Editor #503

This week I was wandering around the halls of the Consumer Electronics Show in Las Vegas and believe me the future of technology means that more of our patients will have less reason to get off the couch. There were great displays by software developers for activity related games such ...

Read More »

Letter from the Editor #502

Happy New Year from all of us at Diabetes in Control. We look forward to bringing you another year of the best in information, tools and articles from the world’s experts. Diabetes care has now moved to the electronic forefront as the Consumer Electronics show in Las Vegas this week ...

Read More »